Last Updated: 04/06/07
BRB Scientific Advances
- Co-Development of Diagnostics and Therapeutics
- Methodology Development in Computational Cancer Biology and Statistical Genomics
- Clinical Trials Designs for the Development of Cytostatic Drugs
- Surrogate Endpoints
- Early Release of Interim Data in Randomized Clinical Trials
- Multiple Comparisons and Clinical Trials
- Sample Size Calculations for Trials with Historical Controls
- Evaluating Treatment Effects in the Presence of Competing Risks
- Longitudinal Data Analysis
- Evaluating Diagnostics in the Absence of a Gold Standard
